Get the Stockscreener App
1.51
5.03%
-0.08
Nucana Plc Adr stock is traded at $1.51, with a volume of 33,116.
It is down -5.03% in the last 24 hours and up +14.83% over the past month.
NuCana PLC is a biopharmaceutical company focused on improving treatment outcomes for cancer patients by ProTide technology. Utilizing proprietary ProTide technology, the firm is developing new medicines designed to overcome key cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells. The company's ProTide pipeline products are NUC-3373, NUC-7738, Acelarin. Geographically operates through the region of the United States and the United Kingdom.
See More
Previous Close:
$1.59
Open:
$1.64
24h Volume:
33,116
Relative Volume:
0.67
Market Cap:
$6.47M
Revenue:
-
Net Income/Loss:
$-41.08M
P/E Ratio:
-0.0453
EPS:
-33.3184
Net Cash Flow:
$-9.93M
1W Performance:
+4.86%
1M Performance:
+14.83%
6M Performance:
-24.50%
1Y Performance:
-59.52%
1-Day Range:
$1.51
$1.64
1-Week Range:
$1.40
$1.665
52-Week Range:
$1.21
$7.22
Nucana Plc Adr Stock (NCNA) Company Profile
Compare NCNA vs VRTX, REGN, ARGX, RVMD, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NCNA
Nucana Plc Adr
|
1.555 | 6.62M | 0 | -41.08M | -9.93M | -33.32 |
VRTX
Vertex Pharmaceuticals Inc
|
515.63 | 128.19B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
807.01 | 82.72B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
991.71 | 53.26B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
213.05 | 43.66B | 742.00K | -1.37B | -1.07B | -7.0731 |
ONC
Beone Medicines Ltd Adr
|
362.46 | 39.31B | 5.76B | 514.49M | 1.10B | 4.4813 |
Nucana Plc Adr Stock (NCNA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-30-24 | Downgrade | William Blair | Outperform → Mkt Perform |
| Mar-03-22 | Downgrade | Cowen | Outperform → Market Perform |
| Oct-22-20 | Initiated | Truist | Buy |
| Jul-24-20 | Initiated | Oppenheimer | Outperform |
| Aug-19-19 | Initiated | H.C. Wainwright | Buy |
| Oct-19-18 | Initiated | Piper Jaffray | Overweight |
| Oct-23-17 | Initiated | Citigroup | Buy |
| Oct-23-17 | Initiated | Jefferies | Buy |
| Oct-23-17 | Initiated | William Blair | Outperform |
View All
Nucana Plc Adr Stock (NCNA) Latest News
NCNA climbs nearly 5% after reporting Q2 results and progress in anti-cancer drug trials - Traders Union
NuCana stock rises nearly 5% as firm intraday buying and mixed technical signals drive demand - Traders Union
Why is NuCana stock up today? Resistance levels in focus - tradersunion.com
12 Health Care Stocks Moving In Friday's Intraday Session - Sahm
NuCana stock rally: Technical outlook - Traders Union
NuCana shares technical analysis: $1.21 support under pressure - Traders Union
Why is NuCana stock rising today? Strong intraday buying limits further downside - Traders Union
NUCANA PLC-ADR (NCNA) Stock Chart - ChartMill
Why is NuCana stock up 4.4% today? - Traders Union
What's behind NuCana's latest stock pullback? - Traders Union
NuCana stock slides 3.29% as sellers keep short-term control - Traders Union
NuCana plc Sponsored ADR Actuals & Estimates (NASDAQ:NCNA) - TradingView
NuCana stock trades up as sellers keep pressure on short-term movement - Traders Union
NuCana stock price forecast: $1.61 support as NCNA falls 7.65% - Traders Union
NuCana stock price forecast: $1.76 support comes into focus as NCNA drops 3.66% - Traders Union
NuCana stock gains 3.49% as short-term rally lifts price to session highs - Traders Union
NuCana stock rises with selling momentum still in control - Traders Union
Buying pressure lifts NuCana stock higher in today's trading - Traders Union
Why is NuCana stock down today? - Traders Union
-2.34% for NuCana stock as further selling slows with oversold pressures - Traders Union
What triggered NuCana shares' latest price surge - Traders Union
What triggered NuCana shares' latest price pullback - Traders Union
Dominance from sellers pushes NuCana stock lower - Traders Union
What is behind NuCana stock's recent gain in value today - Traders Union
Long-term average below current price lifts NuCana stock by 4.24% - Traders Union
What is behind NuCana stock's recent drop in value today - Traders Union
Accelerating downside momentum pushes NuCana stock lower - Traders Union
NuCana stock extends losses as trading stays well below the long-term average - Traders Union
Fading momentum sends NuCana stock down to $2.21 - Traders Union
NCNANuCana plc ADR Volatility & Greeks - Finviz
NuCana stock falls 3.52% as short-term pullback risk rises - Traders Union
NuCana shares jump as stock buying pressure builds - Traders Union
NuCana stock advances as short-term upswing meets resistance - Traders Union
NuCana stock trades higher amid loss of trend strength for further upside - Traders Union
NuCana shares dip amid rising selling pressure - Traders Union
NuCana stock climbs 3.03% as price holds in tight $2.00–$2.08 range - Traders Union
NuCana stock price forecast: $2.31 resistance as NCNA posts 10.10% gain - Traders Union
NuCana Reports First Quarter 2026 Financial Results and Provides Business Update - ChartMill
+3.23% for NuCana stock as price rebounds after pronounced underperformance - Traders Union
Nucana Plc Adr Stock (NCNA) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.24%
1.78%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):